- Home
- VNRX vs MXE Comparison
VNRX vs MXE Comparison
Compare VNRX & MXE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNRX
- MXE
- Stock Information
- Founded
- VNRX N/A
- MXE 1990
- Country
- VNRX United States
- MXE United States
- Employees
- VNRX N/A
- MXE N/A
- Industry
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- MXE Finance Companies
- Sector
- VNRX Health Care
- MXE Finance
- Exchange
- VNRX Nasdaq
- MXE Nasdaq
- Market Cap
- VNRX 52.4M
- MXE 45.0M
- IPO Year
- VNRX N/A
- MXE N/A
- Fundamental
- Price
- VNRX $0.80
- MXE $10.06
- Analyst Decision
- VNRX Strong Buy
- MXE
- Analyst Count
- VNRX 5
- MXE 0
- Target Price
- VNRX $3.88
- MXE N/A
- AVG Volume (30 Days)
- VNRX 307.1K
- MXE 5.8K
- Earning Date
- VNRX 08-13-2025
- MXE 01-01-0001
- Dividend Yield
- VNRX N/A
- MXE 2.66%
- EPS Growth
- VNRX N/A
- MXE N/A
- EPS
- VNRX N/A
- MXE N/A
- Revenue
- VNRX $1,308,361.00
- MXE N/A
- Revenue This Year
- VNRX $563.72
- MXE N/A
- Revenue Next Year
- VNRX $160.43
- MXE N/A
- P/E Ratio
- VNRX N/A
- MXE N/A
- Revenue Growth
- VNRX 64.16
- MXE N/A
- 52 Week Low
- VNRX $0.40
- MXE $8.40
- 52 Week High
- VNRX $0.94
- MXE $11.51
- Technical
- Relative Strength Index (RSI)
- VNRX 75.61
- MXE 53.74
- Support Level
- VNRX $0.40
- MXE $10.15
- Resistance Level
- VNRX $0.75
- MXE $10.22
- Average True Range (ATR)
- VNRX 0.08
- MXE 0.08
- MACD
- VNRX 0.02
- MXE -0.04
- Stochastic Oscillator
- VNRX 69.33
- MXE 29.27
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.
About MXE Mexico Equity and Income Fund Inc. (The)
Mexico Equity and Income Fund Inc is a closed-end, non-diversified management investment company. It maintains an investment objective of long-term capital appreciation through investments in securities, primarily equity, listed on the Mexican Stock Exchange. The company provides a vehicle to investors who wish to invest in Mexican companies through a managed non-diversified portfolio as part of their overall investment program.